Assessing Charles River Laboratories (CRL) Valuation After Recent Share Price Rebound

Charles River Laboratories International (CRL) has seen a recent share price rebound of 19.2% over the last month, following a 19.3% decline in the prior three months. While one popular narrative suggests the company is 41.6% undervalued with a fair value of $313.61, Simply Wall St’s Discounted Cash Flow model indicates it might be overvalued at $183.10, estimating a fair value of $134.61. Investors are encouraged to review the underlying data given these conflicting valuations.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin